• UDP Glucuronosyltransferase 2B15 (UGT2B15) Genotyping
  • Lysosomal Acid Lipase, Enzyme Activity
  • Mycoplasma pneumoniae Antibody, CF (CSF)
  • Urea Nitrogen (BUN), Random, Urine
  • Phosphorus (Phosphate), Serum
  • Beryllium, Serum
  • Albumin, 24 Hour, Urine
  • Alpha Fetoprotein (AFP), Spinal Fluid
  • PPP2R2B (Protein Phosphatase 2 Regulatory Subunit Beta) Gene Mutation Analysis
  • Connective Tissue Disease Profile (Extractable Nuclear Antigen Antibody Panel)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management
Medical Test

Interpretation
Access to Guardant360 TissueNext™, Lung and Breast Cancer Therapy Management is restricted.
Loading...